BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19132484)

  • 1. Heterogeneous prognoses of patients with tumors invaded within muscularis propria according to tumor depth in the layers of the muscularis propria.
    Imamura Y; Baba Y; Ishikawa S; Hiyoshi Y; Nagai Y; Nakamura T; Hayashi N; Miyanari N; Iyama K; Baba H
    Gastric Cancer; 2008; 11(4):219-25. PubMed ID: 19132484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel subclassification of pT2 gastric cancers according to the depth of muscularis propria invasion: superficial muscularis propria versus deep muscularis propria/subserosa.
    Sun Z; Zhu GL; Lu C; Guo PT; Huang BJ; Li K; Xu Y; Wang ZN; Xu HM
    Ann Surg; 2009 May; 249(5):768-75. PubMed ID: 19387327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep muscularis propria tumor invasion without lymph node metastasis as a unique subclassification of stage IB gastric cancer: a retrospective study.
    He K; Chen C; Xia L; Si L; Pan X; Sun Z; Wang Y; Jiang Y; Shi Y; Zhou B; Wang S; Han J; Shen B; Zhou G; Lu J; Wang X
    BMC Gastroenterol; 2022 Jan; 22(1):30. PubMed ID: 35062873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between superficial muscularis propria and deep muscularis propria infiltration in gastric cancer patients: A retrospective cohort study.
    Zhang WH; He D; Chen DN; Li TT; Chen XZ; Yang K; Liu K; Zhang B; Chen ZX; Zhou ZG; Hu JK
    Medicine (Baltimore); 2016 Jul; 95(29):e4165. PubMed ID: 27442638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of lymph node metastatic pattern according to the depth of in-growth in the muscularis propria in T2 rectal cancer for lateral lymph node dissection.
    Komori K; Kanemitsu Y; Ishiguro S; Shimizu Y; Sano T; Kato T
    Dig Surg; 2011; 28(5-6):352-9. PubMed ID: 22042151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Implication of Tumor-invasive Status into the Muscularis Propria in T2 Gastric Cancer.
    Nakamura K; Ogimi M; Tomioku M; Hara H; Nabeshima K; Nomura E
    In Vivo; 2019; 33(4):1341-1346. PubMed ID: 31280228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastasis in gastric cancer in the upper third of the stomach--surgical treatment on the basis of the anatomical distribution of positive node.
    Kitamura K; Nishida S; Yamamoto K; Ichikawa D; Okamoto K; Taniguchi H; Yamaguchi T; Sawai K; Takahashi T
    Hepatogastroenterology; 1998; 45(19):281-5. PubMed ID: 9496527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer with invasion limited to the muscularis propria.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Kikuchi S; Yamauchi H
    Int Surg; 1999; 84(1):7-12. PubMed ID: 10421010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer.
    Cai J; Ikeguchi M; Maeta M; Kaibara N
    Surgery; 2000 Jan; 127(1):32-9. PubMed ID: 10660756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node metastasis risk according to the depth of invasion in early gastric cancers confined to the mucosal layer.
    Kim YI; Lee JH; Kook MC; Lee JY; Kim CG; Ryu KW; Kim YW; Choi IJ
    Gastric Cancer; 2016 Jul; 19(3):860-8. PubMed ID: 26304170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical merit of subdividing gastric cancer according to invasion of the muscularis propria.
    Ishigami S; Natsugoe S; Miyazono F; Hata Y; Uenosono Y; Sumikura S; Matsumoto M; Tokuda K; Nakajo A; Hokita S; Aikou T
    Hepatogastroenterology; 2004; 51(57):869-71. PubMed ID: 15143936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The operative indications for proximal gastrectomy in patients with gastric cancer in the upper third of the stomach.
    Kitamura K; Yamaguchi T; Nishida S; Yamamoto K; Ichikawa D; Okamoto K; Taniguchi H; Hagiwara A; Sawai K; Takahashi T
    Surg Today; 1997; 27(11):993-8. PubMed ID: 9413049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of histologic diversity contributes to not only invasiveness but also lymph node metastasis in early gastric cancer.
    Lee HW; Kim K
    Pathol Res Pract; 2017 Sep; 213(9):1023-1028. PubMed ID: 28864348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depth of
    Seder CW; Mahon B; Hennon M; Thomas M; Levea CM; Matkowskyj KA; Krishna M; Medairos R; Macke RA; Basu S; Blasberg JD
    Anticancer Res; 2018 Apr; 38(4):2195-2200. PubMed ID: 29599339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced gastric cancer with early cancer macroscopic appearance: is it worthy of D2 lymphadenectomy?
    Sun Z; Wang ZN; Zhu GL; Huang BJ; Li K; Xu Y; Li DM; Xu HM
    Ann Surg Oncol; 2010 May; 17(5):1278-90. PubMed ID: 20058192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The validity of sentinel lymph node biopsy using dye technique alone in patients with gastric cancer.
    Rino Y; Takanashi Y; Hasuo K; Kawamoto M; Ashida A; Harada H; Inagaki D; Hatori S; Ohshima T; Yamada R; Imada T
    Hepatogastroenterology; 2007 Sep; 54(78):1882-6. PubMed ID: 18019740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of lymph node metastases from early gastric cancer in relation to depth of invasion: experience in a single institution.
    Wang Z; Ma L; Zhang XM; Zhou ZX
    Asian Pac J Cancer Prev; 2014; 15(13):5371-5. PubMed ID: 25041004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival analysis of gastric cancer limited to the subserosa.
    Lisborg PH; Jatzko GR; Denk H; Klimpfinger MH; Stettner HM
    Z Gastroenterol; 1997 Sep; 35(9):663-8. PubMed ID: 9360292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinical evaluation of patients with T2 gastric cancer.
    Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
    Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.